tiprankstipranks
Trending News
More News >
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
US Market

Lexeo Therapeutics, Inc. (LXEO) Income Statement

Compare
242 Followers

Lexeo Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), Lexeo Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Lexeo Therapeutics, Inc.'s net income was $-20.28M. See Lexeo Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 654.00K$ 1.66M$ 518.48K
Gross Profit
$ 0.00$ 0.00$ 654.00K$ 1.66M$ 518.48K
Operating Expenses
$ 105.77M$ 68.51M$ 61.16M$ 52.29M$ 5.11M
Depreciation and Amortization
$ 2.00M$ 1.84M$ 1.15M$ 13.00K$ 0.00
EBITDA
$ -96.19M$ -64.35M$ -58.04M$ -50.61M$ -4.59M
Operating Income
$ -105.77M$ -68.51M$ -60.51M$ -50.64M$ -4.59M
Other Income/Expenses
$ 7.43M$ 2.12M$ 1.23M$ 15.00K$ -565.00K
Pretax Income
$ -98.33M$ -66.39M$ -59.28M$ -50.62M$ -5.15M
Net Income
$ -98.33M$ -66.39M$ -59.28M$ -50.62M$ -5.15M
Per Share Metrics
Basic EPS
$ -3.09$ -2.49$ -2.36$ -2.01$ -0.20
Diluted EPS
$ -3.09$ -2.49$ -2.40$ -2.01$ -0.20
Weighted Average Shares Outstanding
31.79M 26.65M 25.17M 25.17M 25.17M
Weighted Average Shares Outstanding (Diluted)
31.79M 26.65M 25.17M 25.17M 25.17M
Currency in USD

Lexeo Therapeutics, Inc. Earnings and Revenue History